TAURUS Endoscopy AND RDS WINNERS OF THE 2022-2023 STATE INNOVATION COMPETITION

TAURUS Endoscopy AND RDS WINNERS OF THE 2022-2023 STATE INNOVATION COMPETITION

Jul 17, 2023 | News

TAURUS Endoscopy, an IHU spinoff company, and RDS (Rhythm Diagnostic Systems), long-term partner of the IHU, are winners of the 2022-2023 State Innovation Competition. The awards ceremony was held on Tuesday, July 4, 2023, in the presence of Sylvie Retailleau, Minister for Higher

Education and Research, Roland Lescure, Minister for Industry, Jean-Noël Barrot, Minister for Digital Transition and Telecommunications, and Bruno Bonnell, General Secretary for Investment in charge of France 2030.

To promote the emergence of major French champions on the international stage and encourage entrepreneurial spirit in deeptech, the French State Innovation Competitions have been rewarding researchers and entrepreneurs throughout France since 1999.

Bruno Mutet, President and co-founder, Mariel Bolhouse, CEO and co-founder, and Lee Swanström, member of the Scientific Advisory Board, have accepted the iLab Grand Prix for TAURUS Endoscopy. The company develops innovative medical devices for flexible interventional endoscopy based on revolutionary clip technology.

The i-Lab prize promotes the results of public research through the creation of innovative technology companies. For the 2023 edition, the jury of experts singled out 79 winners from among the 400 applications received for the national competition, particularly in the healthcare, digital and chemical sectors.

CEO Elie Lobel received the iNov award on behalf of RDS. RDS offers hospitals the MultiSense® solution for continuous, accurate remote monitoring, enabling physiological follow-up of patients even within the comfort of their own homes. This is a miniaturized, connected medical device, manufactured in France, which enables very high-quality remote monitoring (continuously over several days) of key cardiac and respiratory parameters, particularly during post-surgical monitoring.

The i-Nov program supports innovation projects by start-ups and SMEs with particularly strong potential for the French economy, with the aim of fostering the emergence of leading companies with global reach. In total, 108 winners were selected for waves 9 and 10 of the competition, for a total of €80 million.

BRAVO to TAURUS and RDS. We are proud of your success!

First official visit of Kazakhstan and Kyrgyzstan officials at IHU Strasbourg

First official visit of Kazakhstan and Kyrgyzstan officials at IHU Strasbourg

Jul 5, 2023 | Event, News, VIP

The IHU Strasbourg had the honour of receiving a delegation of the governments of Kazakhstan and Kyrgyzstan on Thursday 29 June 2023.

The Consul General and Representative to the Council of Europe, Mr Anuarbek Akhmetov represented the Republic of Kazakhstan. Representing the Kyrgyz Republic was Mr Bakyt Dzhangaziev, Deputy Minister of Health and Head of Digital Development.

Also present were eminent members of the public and private healthcare, research, and educational sectors in both Kazakhstan and Kyrgyzstan. The visitors were accompanied by Mr Michaël Galy, CEO of the Strasbourg University Hospital, a founding member of the IHU Strasbourg.

The purpose of the visit, which was part of a ‘grand tour’ of the French healthcare infrastructure, was to facilitate bilateral cooperation in research and education in the healthcare domain. As a representative of the IHU model in France, the IHU Strasbourg showcased its activities and facilities dedicated to research, education, and patient care.

The fruitful discussions bode well for mutual support between the IHU and its Central-Asian colleagues, and we look forward to further collaboration.

Prof. Nicolas Padoy awarded €1.95 million ERC grant for ambitious digital surgery project – CompSURG

Prof. Nicolas Padoy awarded €1.95 million ERC grant for ambitious digital surgery project – CompSURG

Jun 8, 2023 | Economy, Innovation, News, Research

IHU Strasbourg Scientific Director and University of Strasbourg Professor, Nicolas Padoy, head of the CAMMA research team, has been awarded the prestigious ERC Consolidator Grant for his project entitled “Computational Methods to Analyse Intra-operative Adverse Events in Surgery at Scale (CompSURG).” The grant, worth 1.95 million euros, will fund his research over a span of five years. By bridging the fields of artificial intelligence and digital surgery, this ambitious project aims to improve surgical safety and, consequently, patient safety.

 

CompSURG aims to develop a novel computational methodology for analyzing intra-operative adverse events (IAEs) from surgical videos on a large scale. Currently, IAEs are under-reported, hindering their thorough analysis, the establishment of appropriate safety measures, and the development of intraoperative assistance systems to reduce their occurrence. Recent studies have shown that IAEs, while previously considered inconsequential, may in fact be indicative of serious complications and poor surgical outcomes.

Building on these findings, CompSURG will propose a radically new computational approach to improve intra-operative surgical safety, with a specific focus on automatic recognition and analysis of surgical activities and IAEs in endoscopic videos. This will involve developing novel cutting-edge computer vision and machine learning techniques to achieve groundbreaking models of the intricate interactions between surgical tools and anatomy, examine activity patterns and variability on a large scale, and identify critical steps requiring safety measures.

ERC Consolidator Grants are highly competitive awards bestowed upon outstanding researchers regardless of their nationality or age. The sole criterion for selection is scientific excellence. Recipients of the grant should have between seven and twelve years of post-doctoral experience and conduct their research in a public or private research organization located in an EU member state or associated country. The funding primarily supports the employment of researchers and staff to strengthen the recipients’ teams and is awarded for a maximum duration of five years.

The joint IHU – University of Strasbourg CAMMA research team led by Prof. Nicolas Padoy aims at developing new tools and methods based on computer vision, medical image analysis and machine learning to perceive, model, analyze and support clinician and staff activities in the operating room using the vast amount of digital data generated during surgeries. Nested in the IHU building, the team benefits from a unique infrastructure and eco-system with the university hospital and IRCAD.

Camma
IHU
Université de Strasbourg
“France 2030”: 12 new IHUs created

“France 2030”: 12 new IHUs created

May 30, 2023 | Agenda, Economy, Event, Innovation, News, Research

IHU France welcomes this initiative by the French government to promote the unique model of excellence and acceleration of innovation in healthcare

On May 16, 2023, the French President announced the creation of 12 new University Hospital Institutes (IHUs) as part of the France Santé 2030 scheme. The Alliance IHU France, which brings together FOReSIGHT, IHU ICAN, IHU Strasbourg, Institut du Cerveau, Institut Imagine and Liryc, congratulates the newly appointed IHUs and welcomes this government initiative, which validates the strength of the IHU model by extending it to new medical and scientific themes. This reinforcement is part of a shared ambition for innovation and excellence in biomedical research in France.

IHU: accelerating innovation to invent the medicine of the future

Emblematic creations of the Programme d’Investissement d’Avenir (PIA), the IHUs have been given the mission of accelerating innovation in healthcare for the benefit of patients. The rejection of ivory towers, agility and the development of synergies have encouraged the emergence of excellent biomedical innovations and their transfer to the business world.

Created in 2011, the IHUs bring together research, care, development and training in a single location, and are now fully recognized as third-party experimentation centers. The IHUs have become major players in university hospital research, thanks to their scientific excellence, as demonstrated by their attractiveness for competitive research funding. They are also key partners for industrial companies involved in healthcare innovation.

In less than 10 years, the IHUs have achieved tangible results: over 320 patents filed, 18,000 scientific publications, 1,000 new clinical trials, 45 start-ups created, over 600 million euros in co-financing raised, and induced economic development in excess of 1 billion euros, while State investments represent 277 million euros*, i.e. a leverage effect of 5 to 7.

These new IHU and bioclusters will complement the fields of research already covered by the existing institutes: genetic, visual, cardiometabolic and nutritional diseases, central nervous system, cardiac rhythm, image-guided surgery and emerging infections.

IHU France is delighted to welcome the new IHUs:

  • VBHI, Bordeaux, cerebral vascular diseases, IHU
  • Prism, Villejuif, oncology, IHU
  • re-Connect, Paris, hearing disorders, IHU
  • Prometheus, Garches, sepsis, IHU
  • Thema-2, Paris, hematology, IHU
  • Cancers des femmes, Paris, gynecological cancers, IHU
  • Everest, Lyon, liver pathologies, IHU
  • RespirERA, Nice, respiratory pathologies, IHU
  • IMMUN4CURE, Montpellier, immunotherapies, IHU
  • InovAND, Paris, pediatric neurodevelopment, IHU
  • HealthAge, Toulouse, gerontology and aging, emerging IHU
  • Infiny, Nancy, inflammatory bowel diseases, emerging IHU

IHU France is also delighted with the accreditation of 4 new bioclusters, in particular the Brain & Mind biocluster, which brings together three of the Alliance’s IHUs (Institut du Cerveau, Institut de la Vision and Institut Imagine) and two new ones accredited today (InovAND and re-Connect), and the GenoTher biocluster, of which Institut Imagine is a partner.

With the IHU, the French government aims to make France the leading European nation for innovation in healthcare, and to achieve nationally independence in healthcare.

The success of this new call for IHU projects illustrates the effectiveness of the model, now firmly anchored in the medical innovation ecosystem. With these 12 new IHUs, France now has a new capacity to accelerate and innovate in healthcare in priority areas such as complex data mining, personalized care pathway modeling, diagnostic, therapeutic and preventive simulation using digital twins, and disruptive innovations such as gene and cell therapies for patients. The aim of this combined expertise is to multiply diagnostic capabilities, medical and surgical decision support, and treatments.

The challenge now is to make IHU France a tool for meeting international demands and remaining as responsive and competitive as possible, so as to make France the leading European nation for innovation and achieve sovereignty in healthcare.

The Innovation Santé 2030 plan launched by the government was conceived precisely with this ambition, making a commitment in June 2021 to a strong, value-creating industry to bring, with the impetus of the Secrétariat Général pour l’Investissement (SGPI) and the Agence Innovation en Santé (AIS), direct, concrete solutions to patients and the medical community.

About IHU France

Emblematic creations of the “Investissements d’Avenir” program, the IHUs have been given the mission of integrating and accelerating the action processes of hospital and university research, to disseminate biomedical innovations more rapidly to patients and the economic fabric. IHU France brings together the 6 IHUs: FOReSIGHT, ICM (Institut du Cerveau), IHU ICAN, IHU Strasbourg, Imagine (Institut des maladies génétiques) and Liryc (L’institut des maladies du rythme cardiaque), which combine their strengths, initiatives and proposals to accelerate medical innovation in France. The IHUs have demonstrated́ the power of a model of excellence bringing together in a single location all the expertise that enables medical research to be transformed into innovation for the benefit of patients.

* In 2018, the FOReSIGHT IHU was awarded €50 million in funding under the PIA 3 IHU call for projects. In 2019, the 5 other IHUs in the Alliance IHU France were awarded a further 63 million euros.

IHU Strasbourg is part of the pan European TEF-Health consortium, bridging the gap between research and market in healthcare AI and robotics

IHU Strasbourg is part of the pan European TEF-Health consortium, bridging the gap between research and market in healthcare AI and robotics

Mar 16, 2023 | Agenda, Economy, News

The IHU Strasbourg is among 52 partners from 9 countries of the European Union to launch the TEF-Health project.

The consortium, led by the Charité Hospital in Berlin, aims to develop TEFs – Testing and Experimentation Facilities – to bridge the gap between research and the market, and is co-financed by the European Union for the 5-year duration of research and implementation activities.

Pushing the boundaries of the evaluation of artificial intelligence and robotics in the healthcare sector, the consortium aims to set up testing facilities, including both infrastructure and the definition of best practices protocols in line with European standards, that will facilitate innovation and experimental research. The overarching goal is to improve patient care and ensure compliance with legal, ethical, quality and interoperability standards.

The IHU’s clinical and GPL-compliant preclinical facilities and world-class experienced Research, Medical and Innovation teams will be instrumental in guiding client company teams in the project from planning to implementation.

IHU Strasbourg is a member of the French node, led by the LNE (Laboratoire national de métrologie et d’essais), together with the University Hospitals of Rennes, Grenoble Alpes and Lyon, University Grenoble Alpes, EIT Health and CEA Clinatec.